This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

What gives you confidence that Dupixent improves patients’ quality of life?

Learn more

The InRange Study

Learn more

Patients Factors & Impacts

Learn more

Myeloma Facts

Learn more

What is your experience with Dupixent in your practice?

Learn more

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Learn more

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Learn more

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

Learn more

SoliMix Study Results Summary

Learn more

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Learn more

T1D Treatment Practice and the SAGE Study

Learn more

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Learn more

Science at Sanofi

Filters

Therapeutical Areas

Type of Content

What gives you confidence that Dupixent improves patients’ quality of life?

The InRange Study

Patients Factors & Impacts

Myeloma Facts

What is your experience with Dupixent in your practice?

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

SoliMix Study Results Summary

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

T1D Treatment Practice and the SAGE Study

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

You Will Now Be Leaving the Site